ENTITY
Celltrion

Celltrion (068270 KP)

22
Analysis
Health CareSouth Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
05 Feb 2017 16:08

Revisiting Samsung BioLogics at This Interesting Time

I don't really intend to make any investment recommendation on BioLogics at this point. I have to admit that I'm still feeling the current price is...

Logo
248 Views
Share
31 Jan 2017 22:29

Korea Stock Market Monthly Recap #10 - (January 2017)

The Trump economic hope continued to positively impact emerging markets, including Korea. KOSPI was up 2% in January 2017, versus our model...

Logo
323 Views
Share
30 Jan 2017 09:45

Whale Watching in the Korea Stock Market

There is an adage in the financial market that says, "Don't fight the FED." In the Korea Stock Market, there is an adage that says, "Don't fight...

Logo
247 Views
Share
bearishCelltrion Inc
20 Jan 2017 20:59

Recent Developments Not Encouraging

This Insight provides an update on developments in the US market related to biosimilars, and are of great significance to Celltrion Inc (068270...

Share
bullishEubiologics
13 Jan 2017 00:29

Eubiologics IPO Part 3 - IPO Bookbuilding Results & Personal View

Eubiologics IPO price was set at ₩6,000, the lowest end of the indicative price band, after conducting the demand survey (bookbuilding) (Jan 9-10)...

Logo
471 Views
Share
x